Carregant...
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
BACKGROUND: Vortioxetine is the first mixed serotonin agonist and antagonist antidepressant approved in the US. We sought to evaluate all published and unpublished data available to determine the efficacy and harms of vortioxetine in adults with major depressive disorder. METHODS: We used a predefin...
Guardat en:
| Publicat a: | Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4351824/ https://ncbi.nlm.nih.gov/pubmed/25874839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-015-0001-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|